❤️ AI-Powered Platform
Experience the New Standard in AI Remote Cardiac Monitoring
The Implicity platform¹ is associated with a 26% reduced mortality and 4% reduction in hospitalization length compared to conventional remote monitoring².
🔍 AI-powered clarity
The AI-Powered Platform for Remote Cardiac Monitoring
Our platform unifies all cardiac device data into a single intelligent system designed for faster decisions and efficient remote monitoring.
- Unified Device Data: Centralizes and standardizes all cardiac implantable device data into one platform.
- AI-Driven Alert Management: Filters alerts with FDA-cleared algorithms³ and highlights clinically relevant events for faster decisions.
- Smart Workflow Automation: Provides real-time access anywhere and automates billing workflows and reporting.
🌟 Your benefits
The key advantages that make our platform smarter, faster, and more efficient.
Our platform is trusted by top cardiac specialists for its simplicity and precision, delivering proven clinical impact². It centralizes all device data, reduces unnecessary alerts, and helps care teams act faster with confidence.
A smarter, safer way to monitor every patient backed by real-world results and expert validation.
Cardiovascular Associates of Victoria, Texas
Implicity is the only SaaS agnostic platform for CIED remote monitoring equipped with FDA-cleared AI-driven software as a medical device.
Trusted Partners
🔧 Product Features
The core technologies that power our platform
Our platform is built on advanced, clinically validated technologies³ that simplify remote monitoring, enhance accuracy,
and support faster, more confident decision-making.
ILR ECG Analyzer⁵
Utilize FDA-cleared AI to reduce the number of false positives by 79% when analyzing ECG recordings from patients implanted with Medtronic ILRs, while maintaining a sensitivity of 99%.⁶
InLink
Streamline your In-Clinic data workflow.
Patient Connectivity Management
Reconnect 28%⁷ of patients two days after they disconnect, using automated SMS.
AF Alert Management¹
Detect clinically relevant events proven to lead to an 85% decrease in unnecessary AF alerts compared to alerts transmitted by a cardiac implantable electronic device (CIED)⁸.
Dynamic Billing Engine
Achieve 90%+ billing compliance⁴ with optimized scheduling and auto-generated reports.
SignalHF⁹ Predictive AI
Cardiac remote monitoring platform with FDA-cleared AI to predict hospitalizations.
Our Certifications
MD 687058
¹IM009 AF Alert Management is a CE marked class I medical device (MDD 93/42/EEC), see the instructions for use for more information. Covered under the conditions defined in Article L. 162-52 of the French Social Security Code.
²Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.
³IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information. SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
⁴Jay Ganji, MD, FACC, Cardiologist, Piedmont Cardiovascular, November 2022.
⁵IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information.
⁶Rosier, Arnaud, et al., A novel machine learning algorithm has the potential to reduce by 1/3 the quantity of ILR episodes needing review, European Heart Journal, Volume 42, Issue Supplement_1, October 2021.
⁷Durand, Julien, et al., Using Technology to Improve Reconnection to Remote Monitoring in Cardiac Implantable Electronic Device Patients, Cardiovascular Digital Health Journal, Volume 0, Issue 0 Published: November 23, 2023 DOI.
⁸Lazarus, Arnaud, et al. « Filtering of remote monitoring alerts transmitted by cardiac implantable electronic devices and reclassification of atrial fibrillation events by a new algorithm. » Cardiovascular Digital Health Journal 4.5 (2023): 149-154.
⁹SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
The Implicity platform is a clinical decision support device and is in no way intended to replace the responsibility or clinical judgment of the practitioner. It is designed to optimize data workflows and support medical expertise in patient management.
The user-friendliness, efficiency, enhanced workflow, and customer service have all made a positive impact on our patients and our clinic as a whole.